Gamco Investors INC. ET AL boosted its holdings in Medtronic plc. (NYSE:MDT) by 23.1% in the 4th quarter, Holdings Channel reports. The firm owned 29,314 shares of the medical technology company’s stock after buying an additional 5,494 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Medtronic were worth $2,367,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. BDO Wealth Advisors LLC acquired a new position in Medtronic in the second quarter valued at $103,000. Motco increased its stake in Medtronic by 8.7% during the second quarter. Motco now owns 1,239 shares of the medical technology company’s stock worth $110,000 after acquiring an additional 99 shares during the last quarter. Quadrant Capital Group LLC increased its stake in Medtronic by 21.5% during the second quarter. Quadrant Capital Group LLC now owns 1,639 shares of the medical technology company’s stock worth $114,000 after acquiring an additional 290 shares during the last quarter. Blue Chip Partners Inc. acquired a new stake in Medtronic during the third quarter worth about $118,000. Finally, Westwood Holdings Group Inc. acquired a new stake in Medtronic during the second quarter worth about $151,000. Hedge funds and other institutional investors own 81.91% of the company’s stock.

Several brokerages have commented on MDT. Morgan Stanley upped their price target on Medtronic from $91.00 to $95.00 and gave the stock an “equal weight” rating in a research note on Monday, February 5th. Oppenheimer set a $94.00 price target on Medtronic and gave the stock a “buy” rating in a research note on Friday, January 19th. Cowen restated a “buy” rating and set a $95.00 price target on shares of Medtronic in a research note on Friday, November 3rd. Jefferies Group restated a “buy” rating and set a $99.00 price target on shares of Medtronic in a research note on Thursday, November 23rd. Finally, Stifel Nicolaus upped their price target on Medtronic from $83.00 to $85.00 and gave the stock a “hold” rating in a research note on Wednesday, November 22nd. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. Medtronic has a consensus rating of “Buy” and a consensus price target of $90.10.

In other news, EVP Hooman Hakami sold 26,158 shares of the company’s stock in a transaction dated Friday, January 5th. The stock was sold at an average price of $85.00, for a total value of $2,223,430.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Bryan C. Hanson sold 16,000 shares of the stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $79.02, for a total value of $1,264,320.00. The disclosure for this sale can be found here. Insiders sold 136,684 shares of company stock valued at $11,582,596 in the last ninety days. Company insiders own 0.31% of the company’s stock.

Shares of Medtronic plc. (NYSE MDT) opened at $79.48 on Monday. Medtronic plc. has a 1 year low of $75.71 and a 1 year high of $89.72. The company has a quick ratio of 2.05, a current ratio of 2.40 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $107,576.02, a PE ratio of 17.13, a PEG ratio of 2.19 and a beta of 0.93.

Medtronic (NYSE:MDT) last issued its earnings results on Tuesday, November 21st. The medical technology company reported $1.07 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.99 by $0.08. Medtronic had a return on equity of 12.63% and a net margin of 16.93%. The company had revenue of $7.05 billion during the quarter, compared to the consensus estimate of $7.05 billion. During the same quarter in the prior year, the business earned $1.12 earnings per share. The company’s revenue was down 4.0% compared to the same quarter last year. research analysts expect that Medtronic plc. will post 4.76 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, January 19th. Stockholders of record on Friday, December 29th were given a $0.46 dividend. This represents a $1.84 annualized dividend and a dividend yield of 2.32%. The ex-dividend date of this dividend was Thursday, December 28th. Medtronic’s payout ratio is 50.41%.

COPYRIGHT VIOLATION WARNING: “Gamco Investors INC. ET AL Has $2.37 Million Position in Medtronic plc. (MDT)” was first reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this news story on another publication, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The correct version of this news story can be accessed at https://theolympiareport.com/2018/02/12/gamco-investors-inc-et-al-has-2-37-million-position-in-medtronic-plc-mdt.html.

Medtronic Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc. (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.